| Brian Lawrence, PhD
Brian Lawrence, PhD is currently Senior Vice President and Chief Technology Officer of Hill-Rom. In his role as CTO, Lawrence is responsible for new product development and technology innovation across Hill-Rom's portfolio of products including patient support systems, information technology systems, surgical consumables and positioning systems, patient lifts, and respiratory care devices.
Lawrence joined Hill-Rom in December of 2010 from GE Healthcare where he was Chief Technology Officer for Life Support Solutions. In this role, he led a global team of engineers and scientists in the development of technology and products for medical devices in anesthesia delivery, mechanical ventilation, maternal/fetal care, and surgical/critical care disposables. Prior to his role at GE Healthcare, he was the Executive Manager of the Optical Polymers Laboratory and Leader of Advanced Data Storage at GE Global Research, where he led teams of scientists and engineers in the development of new materials for optical applications including display films, healthcare, and data storage, and he led a corporate initiative to develop next-generation holographic data storage systems.
Before joining GE, Lawrence was President and CEO of Extend Optical Systems Corporation, a company he founded to develop ultra-high speed optical regeneration subsystems for the telecommunications industry. Prior to starting Extend Optical Systems, he was Vice President and Chief Technology Officer of Molecular OptoElectronics Corporation, where he led the R&D and Engineering organization in the development and commercialization of optical modules for the telecommunications industry, including variable optical attenuators and optical amplifiers.
Lawrence holds a Bachelor's and a Master's degree from the Massachusetts Institute of Technology (MIT) and a PhD from the Center for Research and Education in Optics and Lasers (CREOL) at the University of Central Florida. He has published 24 articles in peer reviewed journals, given over 40 conference presentations including invited and plenary talks, and has 40 issued U.S. patents.